CardioVere

With the potential to provide physicians with more accurate data to advance the standard of care, the results of CardioVere’s latest clinical study show a promising future that could empower providers and heart failure patients to screen, manage, and monitor at all points of care.

When compared to MRI in evaluating lower extremity tissue congestion measurement, our patented Molecular Chemical Imaging (MCI) technology performed with great results!

You can take a closer look at the full study here: https://bit.ly/3SUy4Ng